Cargando…
Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
The Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) establishes evidence-based guidelines for utilizing pharmacogenetic information for certain priority drugs. Warfarin, clopidogrel and simvastatin are cardiovascular drugs that carry strong prescribing guidance by CPIC. The respective...
Autores principales: | O’Brien, Travis J., Fenton, Kevin, Sidahmed, Alfateh, Barbour, April, Harralson, Arthur F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622254/ https://www.ncbi.nlm.nih.gov/pubmed/34834577 http://dx.doi.org/10.3390/jpm11111226 |
Ejemplares similares
-
Pharmacogenetics of analgesic drugs
por: Cregg, Roman, et al.
Publicado: (2013) -
Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002) -
Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005) -
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
por: Jessurun, Naomi T., et al.
Publicado: (2021) -
Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)